Cipher Pharmaceuticals Inc.

TSX:CPH Lagerbericht

Marktkapitalisierung: CA$327.5m

Cipher Pharmaceuticals Management

Management Kriterienprüfungen 2/4

Cipher Pharmaceuticals CEO ist Craig Mull , ernannt in Jul 2019, hat eine Amtszeit von 5.33 Jahren. besitzt direkt 3.19% der Aktien des Unternehmens, im Wert von CA$10.46M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.5 Jahre bzw. 3.5 Jahre.

Wichtige Informationen

Craig Mull

Geschäftsführender

US$1.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer5.3yrs
Eigentum des Geschäftsführers3.2%
Durchschnittliche Amtszeit des Managements2.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder3.5yrs

Jüngste Management Updates

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Geschäftsführer

Craig Mull

5.3yrs

Amtszeit

US$1,045,700

Vergütung

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 10.5m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 64.0k
Emilio Presti
Director of Sales & Marketing2.8yrskeine Datenkeine Daten
Hamed Ghanei
Chief Business Officerless than a yearkeine Datenkeine Daten

2.5yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: CPHDas Führungsteam des Unternehmens gilt als erfahren (2.5 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 10.5m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 4.7m
Douglas Deeth
Independent Director1.4yrsUS$65.57kkeine Daten
Hubert Walinski
Independent Director1.4yrsUS$62.57kkeine Daten

3.5yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: CPHDie Vorstandsmitglieder gelten als erfahren (3.5 Jahre durchschnittliche Amtszeit).